Please assess the completion status of the following clinical trial:

Trial Title: Effect of Adipokines in Hemodialysis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Overweight (Body Mass Index ≥ 25 kilograms per meter squared (kg/m2))~* Adult (18 years or older)~* Chronic hemodialysis patient~* Diabetic (type 2) or insulin resistant~Exclusion Criteria:~* \<18 years old~* No insulin resistance~* Active liver disease~* Class III or IV New York Heart Association heart failure~* Macular edema or hard exudates near macula on fundoscopy~* Current active malignancy (excluding squamous and basal cell skin cancers)~* Active AIDS~* Chronic lung disease requiring supplemental oxygen therapy~* Enrolled in interventional trials using drugs or devices~* Bone break of long bones, vertebrae, or hips in the past three years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pioglitazone (Type: ACTIVE_COMPARATOR): 15 mg/day pioglitazone for 2 weeks, then 30 mg/day for remaining 24 weeks
- Placebo (Type: PLACEBO_COMPARATOR): 1 placebo pill a day matching the pioglitazone treatment for 26 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).